Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TRPC7 antisense RNA 2 (TRPC7-AS2) is a human long non-coding RNA gene transcribed from the opposite strand of the TRPC7 locus on chromosome 5. Alternative symbols include CTB-28J9.2. It is classified as a long non-coding RNA (lncRNA) and does not encode a protein product. There are currently no documented known functions, biological pathways, disease roles, drug interactions, or safety concerns related to TRPC7-AS2. As an antisense RNA, it may exist to regulate (either positively or negatively) the sense transcript (TRPC7), but its explicit functional relevance has not been detailed in primary genetic or biomedical databases.
Not applicable (This is a non-coding RNA, not a receptor or enzyme target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TRPC7 antisense RNA 2 (TRPC7-AS2).